Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2021 | EpimAb Biotherapeutics | $120.0M Series C | Tony Rong, Sungwon Song | CVentures, Adrian Cheng, Cormorant Asset Management, Decheng Capital, Hony Capital, Octagon Capital, SDIC Fund, ShangBay Capital, Sherpa Healthcare Partners, Yanchuang Capital |
| Dec 30, 2018 | GenFleet Therapeutics | $17.5M Series A | Ally Bridge Group | CSPC Pharma, Sinopharm Capital, TF Capital |
| Jan 9, 2017 | Ascentage Pharma | $72.1M Series B | Future Industry Ventures | Efung Capital, KIP Capital, Oriza Ventures, Shiyu Capital, YuanMing Capital |